Generic Biosimilar Medicines Association

Making Medicines Affordable

Home
About GBMA
Advocacy
Generics
Biosimilars
- GBMA Position on Biosimilars
- Key Figures on Biosimilars
Topics
News
- News 2019
- News 2018
- News 2017
- News 2016
- News 2015
- News 2014
GBMA Education

You are here: Home / Biosimilars / GBMA Position on Biosimilars / Key Figures on Biosimilars

Key Figures on Biosimilars

As focus grows for biosimilars, GBMA welcomes its newest member Celltrion

July 18, 2019

18 July 2019 Canberra, ACT A commitment to drive the uptake of biosimilar medicines in Australia has seen Korean biopharmaceutical … More...

GBMA welcomes Minister Hunt’s return to the Health portfolio

May 26, 2019

26 May 2019 Canberra, ACT The peak body for generic and biosimilar medicines … More...

Budget 2019-20 – Budget spending on health and new medicines a welcome investment in the health of Australians

April 3, 2019

2 April 2019 Canberra, ACT The Generic and Biosimilar Medicines Association (GBMA), … More…

© 2019 Generic Medicines Industry Association Pty Ltd | Site Map | Contact Us